2019
DOI: 10.1080/10426507.2019.1687479
|View full text |Cite
|
Sign up to set email alerts
|

Theoretical study of encapsulation of Floxuridine anticancer drug into BN (9,9-7) nanotube for medical application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 60 publications
0
5
0
Order By: Relevance
“…One of the key challenges of nanocarriers is to encapsulate and release the drug in a nanoparticular form without any chemical modifications at the proper site [16]. BNNT is a high inner volume nanocarrier that encapsulates more drugs and allows them to penetrate open ends [17]. The BNNTs are non-cytotoxic compared to carbon nanotubes (CNTs), with their large bandgap and the independence of electronic properties from the nanotube diameter, which is very chemically stable [18].…”
Section: Introductionmentioning
confidence: 99%
“…One of the key challenges of nanocarriers is to encapsulate and release the drug in a nanoparticular form without any chemical modifications at the proper site [16]. BNNT is a high inner volume nanocarrier that encapsulates more drugs and allows them to penetrate open ends [17]. The BNNTs are non-cytotoxic compared to carbon nanotubes (CNTs), with their large bandgap and the independence of electronic properties from the nanotube diameter, which is very chemically stable [18].…”
Section: Introductionmentioning
confidence: 99%
“…The lightweight yet robust nature of BNNTs, combined with their high neutron attenuation efficiency, make them ideal candidates for protecting spacecraft and astronauts from cosmic radiation. 68,69 Additionally, the potential of BNNTs in medical applications, 22,[70][71][72][73][74][75][76][77][78] particularly in Boron Neutron Capture Therapy (BNCT), for cancer treatment was explored. 70,[79][80][81][82] BNCT leverages the high neutron capture cross-section of boron-10 (3835 barns 26 ) in BNNTs to selectively target and destroy cancer cells, thereby presenting a novel approach in oncology.…”
Section: Dongsu Baementioning
confidence: 99%
“…The theoretical results showed that the interaction between drugs and BNNTs was energetically favorable due to van der Waals interaction. This study helped to understand the interaction between drug molecules and BNNTs to develop drug delivery carriers by using BNNTs [110].…”
Section: Use Of Bnnts In Biomedical Applicationsmentioning
confidence: 99%